Anton Pottegård is a Professor at the University of Southern Denmark and Head of Research at Hospital Pharmacy Funen (Odense University Hospital). His work combines registry-based pharmacoepidemiological research with clinical investigations into deprescribing practices. Affiliation: University of Southern Denmark Secondary Role: Head of Research, Odense University Hospital Research interests focus on pharmacoepidemiology and clinical pharmacy , particularly real-world drug safety and deprescribing in geriatric care. His methodology emphasizes Danish healthcare registries for longitudinal analyses of medication patterns and adverse outcomes. Notable contributions include epidemiological analyses of opioid utilization , migraine treatments , and GLP-1 receptor agonists . He has developed frameworks for pharmacoepidemiological methodology and drug safety surveillance , co-authored over 300 publications, and led the REDO project on reducing opioid use in osteoarthritis. Additional activities include media commentary on TBE vaccination and tick-borne diseases , with 613 press/media appearances reflecting public health engagement. Supervised work includes 7 doctoral candidates and cross-national collaborations.
Professor Graham Ogg is a leading academic at the University of Oxford, where he serves as Professor of Dermatology and leads the Skin Immunology Group. His research focuses on cutaneous immunity, particularly the role of CD1a-restricted T cells in inflammatory skin diseases. He is affiliated with the MRC Human Immunology Unit and MRC Weatherall Institute of Molecular Medicine, driving translational research on lipid antigen presentation and skin immune responses. Professor Ogg's investigations center on molecular mechanisms of skin inflammation, with emphasis on CD1a-mediated T cell activation and its implications for atopic dermatitis, psoriasis, and vaccine development. His work bridges fundamental immunology with clinical applications, exploring how lipid metabolism influences immune pathways in barrier tissues. Research themes include: CD1a-lipid interactions in cutaneous inflammation Therapeutic modulation of skin-specific T cell responses Translational models for dermatological drug delivery Immune mechanisms in allergic skin disorders Analysis of his recent publications (2024-2025) reveals dominant research streams: 1) Clinical dermatology focusing on systemic therapies for atopic eczema, 2) Immunological studies of dengue pathogenesis and metabolic interactions, 3) COVID-19 sequelae and immunity dynamics, and 4) Fundamental T cell biology in autoimmune/inflammatory contexts. This corpus demonstrates interdisciplinary integration of dermatology, virology, and immunometabolism. His scientific recognition includes: Fellowship of the Academy of Medical Sciences (FMedSci) Professor Ogg directs the Skin Immunology Group at the MRC Weatherall Institute, coordinating translational projects that investigate cutaneous immune circuits. The team employs single-cell analysis, spatial transcriptomics, and immunological profiling to dissect skin-specific immune responses, with ongoing work exploring CD1a-targeted therapeutic strategies.
Henrik Møller is a Professor at the Danish Center for Health Services Research , part of the Faculty of Health Sciences at Aalborg University . His work focuses on cancer epidemiology , clinical quality registries , and health services research , particularly examining prostate cancer , lung cancer , and colorectal cancer through nationwide cohort studies. Key research areas: Cancer care quality, pandemic impacts on diagnosis/treatment, socioeconomic disparities Active collaborations in Denmark and England Contributor to national and international cancer registries Recent publications analyze CT imaging trends in lung cancer detection, chemotherapy disparities in pancreatic cancer, and genetic biomarkers in gliomas. His team has released multiple datasets on figshare platforms. As a leader in health services research, Møller's work informs healthcare policy improvements through evidence-based quality indicators and development targets.
Gabriele Capurso is an Associate Professor of Medicine at Vita-Salute San Raffaele University's School of Medicine, Department of Gastroenterology (Disciplinary Sector MEDS-10/A). He teaches Gastroenterology across multiple sections of the Master's Degree in Medicine and Surgery program for the 2025-2026 academic year. His research focuses on pancreatic cancer , IPMN progression , autoimmune pancreatitis , and endoscopic interventions . Key contributions include leading the Italian Chronic Pancreatitis Registry (ITARECIPE) and developing risk-stratification models for IPMN surveillance. His work bridges clinical practice and translational research, emphasizing diagnostic delays, smoking-related progression risks, and endoscopic management of pancreaticobiliary disorders. Analysis of his 2024-2025 publications reveals a concentrated effort on pancreatic disease outcomes, with prominent themes in malignant transformation biomarkers, endoscopic technique validation, and multicenter cohort studies. His research consistently targets improving survival metrics through optimized diagnostic pathways and personalized treatment protocols. Capurso served on Sapienza University of Rome's Oncology doctoral college (2014-2018, cycles 30-34), mentoring PhD candidates. His leadership in national registries and prospective studies like CABRIOLET_Pro demonstrates active engagement in collaborative clinical research infrastructure.
Dr. Laura Oakley is an Associate Professor and Co-Programme Director for the Distance Learning Epidemiology programme at the London School of Hygiene and Tropical Medicine (LSHTM), within the Department of Non-communicable Disease Epidemiology in the Faculty of Epidemiology and Population Health. She also holds an affiliated researcher position at the Centre for Fertility and Health (CeFH) at the Norwegian Institute of Public Health in Oslo, Norway, facilitating international collaborations on perinatal epidemiology using Scandinavian registry data. Dr. Oakley's educational background includes: Undergraduate degree in Sociology from the London School of Economics MSc in Epidemiology from LSHTM PhD from LSHTM focusing on determinants of infertility in women Prior research experience at the Centre for Research in Primary Community Care, University of Hertfordshire Research position at the National Perinatal Epidemiology Unit, University of Oxford (2009-2014) As an epidemiologist specializing in maternal, reproductive, and child health, Dr. Oakley's research spans the epidemiology of infertility, pregnancy complications, perinatal outcomes, effects of in-utero exposures, and infant feeding practices. Her work emphasizes health inequalities and socioeconomic determinants of breastfeeding across diverse global settings. Methodologically, she combines interventional and observational approaches, leveraging large-scale registry data from high-income countries while conducting research in low- and middle-income contexts. Her affiliation with CeFH provides access to exceptional Scandinavian registry linkages that support her perinatal epidemiology research. Dr. Oakley's publication record reveals a strong focus on the intersection of infectious disease (particularly COVID-19) with pregnancy outcomes, reflected in her leadership of the Nordforsk-funded SCOPE projects. She also maintains significant contributions to reproductive health through the British National Surveys of Sexual Attitudes and Lifestyles (Natsal), and leads epidemiological research on sickle cell disease in pregnancy. Her work on breastfeeding patterns across sub-Saharan Africa demonstrates her commitment to understanding long-term health and educational outcomes. Dr. Oakley serves as Co-Programme Director for the Epidemiology by Distance Learning programme at LSHTM, teaching multiple modules including Fundamentals of Epidemiology, Basic Epidemiology, Foundations of Reproductive Health, and Research, Design and Analysis. She provides academic guidance as a personal tutor for MSc Reproductive and Sexual Health Research and MSc Epidemiology students, while supervising research projects. Her grant portfolio includes the Research Council of Norway-funded program on assisted conception and cancer risk, the NIHR-funded TAPS2 feasibility trial on sickle cell disease in pregnancy, and the MRC-funded GUIDES trial on gestational diabetes in Uganda and India. Through her international collaborations with institutions across Norway, Sweden, Denmark, Canada, Uganda, and India, Dr. Oakley maintains a global research perspective that bridges academic epidemiology with practical applications for improving maternal and child health worldwide. Her work on the socioeconomic determinants of breastfeeding and pregnancy outcomes in women with sickle cell disease addresses critical health disparities in maternal care.
Professor Bill Watson is a Full Professor of Cancer Biology at the University College Dublin, School of Medicine , where he serves as Head of Pathology and Director of the Biomedical Health and Life Science BSc program. With a PhD in Biochemistry (University College Cork, 1995) and post-doctoral training at the University of Toronto, he has led translational research in prostate cancer since returning to UCD in 1997. His work focuses on biomarker discovery, therapy resistance mechanisms, and clinical decision tools through the Prostate Cancer Research Consortium and iPROSPECT collaborations. Education: BSc (University College Dublin), PhD (Royal College of Surgeons in Ireland), Post-Doctoral Research Fellow (Toronto General Hospital) His research integrates genomic, epigenetic, and proteomic biomarkers to improve prostate cancer stratification and treatment selection, as demonstrated in the Movember Global Action Plan and ToPCaP initiatives. Recent studies include validating a six-gene MCRS signature for biopsy-based prognostics (2025) and developing beta mixture models for DNA methylation analysis (2024). Scientific Awards include the Alton Prize (2000), Presidents Awards for Teaching (2000, 1998), and Young Investigator Award (1995). He has received grants such as the UCD Equip Scheme (2021) and Molecular Therapeutics for Cancer (2009-2015) . Professional Leadership: Irish Association for Cancer Research (President 2014-2017), Cancer Trials Ireland (Chair of Translational DSSG 2014-present), and Royal Academy of Medicine in Ireland (Fellow since 2006)
Tobias Berg is an Associate Professor of Oncology at McMaster University , affiliated with the Juravinski Cancer Centre (JCC) and the Centre for Discovery in Cancer Research (CDCR) . He leads the Translational Oncology Program , bridging clinical practice and basic research. His work focuses on understanding treatment resistance and relapse mechanisms in Acute Myeloid Leukemia (AML), leveraging epigenetic regulators, metabolic studies, and stem cell transplantation. Key roles include: Member of the Stem Cell and Cellular Therapy Program , specializing in allogeneic transplants and CAR T-cell therapy Principal investigator in clinical trials involving LSD1 inhibitors, venetoclax, and sorafenib Recipient of funding from the Boris Family Chair for Leukemia Research , Canadian Foundation for Innovation, and OICR Research Interests: Berg's lab investigates epigenetic drivers of leukemia relapse post-transplant, novel combination therapies, and biomarkers for early disease detection. Techniques include single-cell sequencing, metabolic profiling, and functional in vitro/in vivo models. His work also addresses residual disease detection through standardized flow cytometry panels (HARMONIZE initiative). Key Trends in Publications: Recent studies highlight: Role of IRF8 and LSD1 in AML drug sensitivity Impact of mixed donor chimerism on transplant outcomes Mechanisms linking metabolism and therapy resistance in FLT3-ITD AML Grants & Collaborations: Leads multicenter trials (e.g., SORMAIN and TRANSATRA) and collaborates with institutions like the Ontario Institute for Cancer Research . His lab is part of the McMaster Cancer Research Stem Cell Bank , collecting patient-derived samples for translational studies.
Ilana Ackerman is a Research Professor in the School of Public Health and Preventive Medicine at Monash University, and Deputy Director of the Musculoskeletal Health Unit. She holds adjunct roles at La Trobe University and serves on international editorial boards for journals like Journal of Patient-Reported Outcomes and Journal of Physiotherapy . Her research focuses on musculoskeletal epidemiology, osteoarthritis burden projections, and patient-reported outcomes in joint replacement surgery. Dr. Ackerman earned a Doctor of Philosophy (2006) and a Bachelor of Physiotherapy (Honours) (1996) from the University of Melbourne. She has received prestigious fellowships, including the NHMRC Public Health Early Career Fellowship and a Victorian Health and Medical Research Fellowship. Her work emphasizes osteoarthritis clinical care standards, including contributions to the Australian Commission on Safety and Quality in Health Care’s Osteoarthritis of the Knee Clinical Care Standards and the Victorian Model of Care for Osteoarthritis. She co-chairs the International Society of Arthroplasty Registries’ Patient-Reported Outcomes Working Group and advises the Australian Orthopaedic Association National Joint Replacement Registry. Recent research highlights include projecting arthritis burden trends in Australia, evaluating exercise therapy programs, and analyzing VTE prophylaxis efficacy post-arthroplasty. Her 15+ awards recognize contributions to musculoskeletal epidemiology and clinical research training. Active in over 25 research projects, she collaborates globally on initiatives like the HERknee CRE to prevent knee injury and osteoarthritis burden. Grants include NHMRC, HCF Research Foundation, and Arthritis Australia funding. She is dedicated to training clinical researchers and fostering clinician engagement to improve arthritis care quality.
Levent Dumenci serves as Professor in the Department of Epidemiology and Biostatistics at Temple University's College of Public Health since July 2015. His NIH-funded research (NIMH, NCI) focuses on psychometric test development and discrete latent variable modeling of behavioral data. He is the author of Latent Kappa and provides statistical consultation for quasi-experimental and non-experimental research designs across public health disciplines. His educational foundation includes: PhD in Psychometrics (Major) and Statistics (Minor) from Iowa State University MS in Psychometrics from Iowa State University BS in Psychology from Hacettepe University Dumenci's research integrates structural equation modeling, multitrait-multimethod matrix specification, and statistical modeling of observed/unobserved heterogeneity. His work advances methodologies for situational specificity of behavioral ratings, latent agreement modeling, and health literacy assessment. This interdisciplinary approach bridges biostatistics, epidemiology, and clinical measurement with emphasis on rigorous quantitative analysis of complex health data. His extensive publication record demonstrates consistent focus on orthopedic outcomes (particularly knee arthroplasty), where he applies advanced statistical techniques to patient-reported outcomes, pain assessment, and recovery trajectories. Significant contributions also appear in cancer health literacy, neighborhood-level adverse childhood experiences indices, and opioid use patterns in surgical recovery. His methodological innovations frequently address limitations in minimal clinically important difference estimation and patient outcome classification. Dumenci actively contributes to academic service through NIH/NSF study sections and editorial boards of two international journals. He mentors students through statistical consultation for externally funded projects and teaches core courses including Biostatistics for Health Professions (EPBI 5001) and Structural Equation Modeling (EPBI 8201). He directs the Biostatistics Core at Temple University, which provides statistical methodology support across public health research domains including clinical trials, observational studies, and community-based interventions. His team specializes in complex data modeling for behavioral health, chronic disease management, and health disparities research.
Edward C. Norton is the UnitedHealthcare Professor of Health Care Management in the Department of Health Management and Policy and a Professor in the Department of Economics at the University of Michigan. He serves as Director of Quantitative Analytics in the Center for Healthcare Outcomes and Policy and is a Research Associate at the National Bureau of Economic Research (Health Economics and Economics of Aging Programs). His work bridges econometric methods with health policy, focusing on long-term care, aging, and pay-for-performance systems. Education: PhD in Economics from MIT (1990), AB in Economics from Princeton University (1986). Research interests span health economics , econometric modeling , aging , and healthcare finance . His recent publications address topics like IVF insurance coverage , robotic surgical outcomes , and dementia-related economic burdens , employing advanced statistical techniques to evaluate policy impacts. He has received the 2018 School of Public Health Excellence in Research Award . His methodological contributions include developing analytical tools for heterogeneous treatment effects and logit model interpretations , with applications in Medicare payment reforms and healthcare quality studies.
Associate Professor Katrin Sjoquist is a Senior Research Fellow and Clinical Lead at the NHMRC Clinical Trials Centre (CTC), part of the Faculty of Medicine and Health at the University of Sydney. She is also a practising medical oncologist specializing in gastrointestinal and rare cancers. Since joining the CTC in 2010, she has focused on clinical trials in oncology, earning a PhD in clinical trial design and evaluation. Her roles include coordinating the AGITG trials and leading the Cancer Australia-funded Genomics Cancer Clinical Trials Initiative (GCCTI) and the Molecular Screening and Therapeutics (MoST) programme. Research Interests: Design and management of Phase II/III clinical trials, evidence-based medicine, gastrointestinal and rare cancers, and evaluating treatment benefits versus harms. Her work spans oncology drug development, precision medicine, and translational research. Publications: Over 100 peer-reviewed articles, including high-impact studies in Journal of Clinical Oncology , Clinical Cancer Research , and British Journal of Cancer . Recent work focuses on regorafenib in gastric cancer, cell-free DNA biomarkers, and clinical trial methodologies. Grants and Leadership: Principal investigator on grants such as the Biliary Tract Registry Development (2023), and leadership roles in international trials like INTEGRATE II and NuTide:121. Collaborates with institutions like the Garvan Institute. Labs/Teams: CTC, AGITG, and MoST programme. Her work emphasizes collaborative, multi-institutional research to advance oncology treatments.
Wilma Nusselder, PhD, is an Assistant Professor in Medical Demography at the Department of Public Health, Erasmus University Medical Center (Erasmus MC), Rotterdam, the Netherlands. She is actively engaged in research at the intersection of public health and demography, with a strong focus on health and mortality inequalities by socioeconomic position, gender, and ethnicity. Her research centers on the development and application of summary measures of population health, particularly health expectancies, to understand both the quantity and quality of life across populations. She investigates how risk factors and chronic diseases influence health trajectories and mortality, and evaluates the impact of public health interventions and policies. Her methodological expertise includes life table analysis, decomposition methods, and modeling frameworks such as DYNAMO-HIA and ERAINHE. The analysis of her recent publications reveals a consistent focus on health disparities, particularly educational and socioeconomic inequalities in life expectancy, disability, and chronic disease. Her work increasingly employs comparative international data, simulation modeling, and policy impact assessment, reflecting a trend toward evidence-based public health strategy and forecasting. Dr. Nusselder is the coordinator of ERAINHE, a collaborative European framework for harmonizing mortality data by socioeconomic position, enabling large-scale comparative research. She teaches medical and PhD students and collaborates extensively with multidisciplinary teams across public health, demography, sociology, and econometrics. She has contributed to numerous research projects and publications assessing the societal and health system impacts of policies, particularly in aging and health equity. Her work aligns with UN Sustainable Development Goal 3 (Good Health and Well-being), especially in reducing health disparities.
Claudia Allemani is Professor of Global Public Health at the London School of Hygiene & Tropical Medicine (LSHTM), where she leads the Cancer Survival Group within the Department of Non-Communicable Disease Epidemiology in the Faculty of Epidemiology and Population Health. With over 20 years of experience in cancer epidemiology, she serves as co-Principal Investigator for the global CONCORD cancer surveillance program and Principal Investigator for the ERC-funded VENUSCANCER project studying worldwide inequalities in cancer survival. Her educational background spans applied mathematics to public health, with degrees including an MSc in Mathematics from the University of Turin (1996), MSc in Statistical and Informatic Methods from the University of Milan (1998), a PhD equivalent in Medical Statistics (2001), and a PhD in Public Health and Education (2006), all from Italian institutions. Professor Allemani's research focuses on international comparisons of cancer survival trends, high-resolution studies on patterns of care, and estimation of avoidable premature deaths with direct impact on cancer policy. Her work encompasses multiple cancer types across more than 70 countries, examining how healthcare systems, socioeconomic factors, and policy interventions affect cancer outcomes globally. She has pioneered methodologies for population-based cancer survival analysis that have become standard in the field. Her extensive publication record demonstrates consistent focus on global cancer surveillance, with particular attention to breast, cervical, and ovarian cancers, as well as pediatric malignancies. The research shows clear evolution from European-focused studies (EUROCARE) to truly global population-based analyses (CONCORD), reflecting growing recognition of cancer as a worldwide health challenge requiring international comparative approaches. Fellow of the Higher Education Academy (2012) Honorary Member of the UK Faculty of Public Health (2014) UK Faculty of Public Health's inaugural Global Public Health Award (2016) European Research Council Consolidator grant recipient (2017) Member of The Lancet Oncology International Advisory Board (2021-2024) Co-Chair of the CONCORD-Lancet Global Commission on Cancer Professor Allemani actively supervises PhD students and teaches across multiple MSc programs at LSHTM, particularly in epidemiology and medical statistics. Her grant portfolio includes major funding from the European Research Council, Cancer Research UK, CDC, WHO, and other international bodies supporting the CONCORD program's expansion to include 22 adult cancers and all childhood cancers diagnosed from 2000-2019 across 70+ countries. She leads a dedicated team of five researchers in the Cancer Survival Group, collaborating with major international health organizations including the Organisation for Economic Co-operation and Development, US Centers for Disease Control and Prevention, Institute for Health Metrics and Evaluation, WHO, International Atomic Energy Agency, and numerous national cancer institutes to translate survival data into actionable cancer control policies worldwide.
Tormod Rogne, MD, PhD, is an Assistant Professor Adjunct in Chronic Disease Epidemiology at the Yale School of Public Health. His research focuses on perinatal epidemiology, with particular interest in how climate change affects pregnancy, modifiable risk factors on reproductive health, and the long-term health consequences of being born preterm. He applies modern epidemiological methods including Mendelian randomization, negative controls, and genetic epidemiological approaches to address clinically relevant questions using high-quality population-based data. MD from Norwegian University of Science and Technology, NTNU (2015) PhD from Norwegian University of Science and Technology, NTNU (2016) Residency at Akershus University Hospital and Ski Municipality (2018) Fulbright Scholar at Yale School of Public Health (2019) Postdoctoral Scholar at Norwegian University of Science and Technology, NTNU (2021) Dr. Rogne's research spans several key areas of perinatal and environmental epidemiology. He investigates how environmental factors like climate change and temperature extremes affect pregnancy outcomes and child health. His work also explores the genetic and environmental determinants of reproductive health and adverse pregnancy outcomes. Of particular note is his research on how being born preterm affects long-term risk of cardiovascular and infectious diseases. Dr. Rogne emphasizes the use of high-quality data from population-based cohorts and national registries, applying sophisticated methods like negative controls, inverse-probability weighting, and genome-wide association analyses to ensure robust findings. His recent publications reveal a strong methodological focus on Mendelian randomization techniques to establish causal relationships in perinatal health. His work spans cardiovascular epidemiology, infectious disease epidemiology, and environmental health, with consistent themes including climate change impacts on pregnancy, socioeconomic determinants of health outcomes, and the developmental origins of disease. The geographic scope of his research includes both high-income settings like Norway and global health contexts in Africa. Fulbright Scholarship (2017) Tom Wilhelmsen Foundation's Research Stipend (2013) Dr. Rogne maintains active collaborations with multiple researchers including Andrew DeWan, Xiaomei Ma, Joshua Warren, Kai Chen, Rong Wang, and Zeyan Liew. His work is supported by various research initiatives including the Fulbright Program and the Tom Wilhelmsen Foundation. He is affiliated with the Yale Center for Perinatal, Pediatric and Environmental Epidemiology, where he contributes to advancing research on women's and children's health through epidemiologic studies investigating environmental, genetic, and clinical factors. As part of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology, Dr. Rogne works within a collaborative team focused on promoting women's and children's health through rigorous epidemiologic research. The Center, originally founded in 1979 as the Yale Perinatal Epidemiology Unit, continues to be a leader in investigating how environmental, genetic, and clinical factors impact pregnancy, birth, and childhood development.
Ambrosi Alessandro is an Associate Professor in Medical Statistics at Vita-Salute San Raffaele University. Holding a PhD in Statistics from the University of Padua (1999), he has contributed extensively to biostatistical methodologies in medical research, particularly in gene therapy, hematology, and computational biology. Degree in Statistics, University of Padua (1996) PhD in Statistics, University of Padua (1999) His research focuses on non-parametric statistical methods, machine learning applications in medicine, and statistical genetics. He has developed analytical frameworks for retroviral integration site mapping and biomarker discovery in preeclampsia and cancer prognosis. Recent work examines placental gene expression in pregnancy complications, orthodontic biomechanics, and cardiovascular risk prediction models. His publications span top-tier journals such as EMBO, Blood, and Nature Biotechnology. Fellow, Cochrane (2024-present) Fellow, Società Italiana di Statistica (2024-present) Fellow, SISMEC (2013-present) Ambrosi has served as a contract professor at the University of Padua and participates in doctoral colleges across Italy. His collaborations include international institutions like the University of Aarhus (Denmark) and the University of Oslo (Norway).
